- Cat. No.
- A10598
MK 3207 HCl
MK 3207 hydrochloride is a potent CGRP receptor antagonist with IC50 of 0.12 nM.
Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
CGRP receptor antagonists block the receptor for calcitonin gene-related peptide (CGRP), a neuropeptide. In 1982 alternative RNA processing of the calcitonin gene was shown to produce CGRP in neural tissue. The receptor is formed by calcitonin receptor-like receptor (CALCRL) together with receptor activity-modifying protein 1 (RAMP1), as described in 1998. CGRP release from trigeminal neurons is studied in migraine models and in neurogenic vasodilation. Olcegepant, telcagepant, MK-3207 and ubrogepant are small-molecule antagonists of this receptor complex. CGRP 8-37 (human) is a truncated peptide antagonist, and α-CGRP(human) serves as the native agonist.
MK 3207 hydrochloride is a potent CGRP receptor antagonist with IC50 of 0.12 nM.
Synonyms: MK-0974
MK-0974 (Telcagepant) is a potent and selective antagonist of the human and rhesus CGRP receptors.
Synonyms: BIBN-4096; BIBN 4096BS
Olcegepant is a potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor with IC50 of 0.03 nM and Ki of 14.4 pM for human CGRP.
BMS-927711 is a potent, selective, competitive human calcitonin gene-related peptide (CGRP) receptor antagonist that has shown in vivo efficacy without vasoconstrictor effect.
MK-3207 is a potent and orally bioavailable CGRP receptor antagonist (IC50= 0.12 nM; Ki value= 0.024 nM); highly selective versus human AM1, AM2, CTR, and AMY3.
Synonyms: HCGRP-(8-37)
HCGRP-(8-37) is a human calcitonin gene-related peptide (hCGRP) fragment and also an antagonist of CGRP receptor.
CGRP antagonist 1 is a highly potent CGRP receptor antagonist with a Ki and IC50 of 35 and 57 nM, respectively.
Synonyms: Calcitonin gene-related peptid
α-CGRP(human) is a regulatory neuropeptide of 37 amino acids. α-CGRP(human) is widely distributed in the central and peripheral nervous system. α-CGRP(human) is a potent vasodilator.
Synonyms: MK-1602
Ubrogepant (MK-1602) is a novel oral calcitonin gene-related peptide receptor (CGRP) antagonist in development for acute treatment of migraine.
Synonyms: BIBN-4096 hydrochloride; BIBN4096; BIBN4096BS hydrochloride; BIBN 4096BS
Olcegepant hydrochloride is the first potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor with IC50 of 0.03 nM and with a Ki of 14.4 pM for human CGRP.
Rat CGRP-(8-37) (VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF) is a highly selective CGRP receptor antagonist.
Synonyms: 22-52-Adrenomedullin (human
Adrenomedullin (AM) (22-52), human, an NH2 terminal truncated adrenomedullin analogue, is an adrenomedullin receptor antagonist, and also antagonizes the calcitonin generelated peptide (CGRP) receptor in the hindlimb vascular bed of the cat.
Synonyms: CGRP free acid
Calcitonin gene-related peptide (CGRP) free acid is a neuropeptide. Calcitonin gene-related peptide can be used for the research of nociception, ingestive behaviour and modulation of the endocrine systems.
PCC0105005 is a potent CGRP receptor antagonist, exhibiting an IC50 of 1.01 nM, coupled with partial agonist activity at the 5-HT1F receptor, with an EC50 of 77.91 nM. This compound demonstrates significant efficacy in preclinical migraine models, effectively reducing the expression levels of CGRP and c-Fos proteins and inhibiting ERK and CREB phosphorylation. PCC0105005 is suitable for research focused on migraine pathophysiology and potential therapeutic interventions.
Out of stock
All 3 sizes
[Tyr22] Calcitonin Gene Related Peptide, (22-37), rat is a CGRP analogue that targets the CGRP receptor and modulates adenylate cyclase activity. This peptide fragment, derived from the rat CGRP sequence, exhibits key biological activities associated with pain modulation and vasodilation. It is suitable for research applications studying neurogenic inflammation, cardiovascular regulation, and the pathophysiology of migraine headaches.
Synonyms: LY-3841136
Eloralintide is an amylin receptor (AMYR) activator designed for long-lasting metabolic effects. This peptide selectively targets amylin receptors while minimizing activation of calcitonin receptors, thanks to its unique C20 fatty diacid modification. Eloralintide has been shown to decrease appetite and contribute to weight reduction, making it a valuable tool for research into obesity and related metabolic disorders.
KBP-089 is a dual agonist of Amylin and Calcitonin receptors. This compound demonstrates significant biological activity by promoting weight reduction, decreasing adipose tissue mass, and enhancing glucose tolerance in obese rat models. Additionally, KBP-089 reduces lipid accumulation in both liver and muscle tissues while improving glycemic homeostasis and insulin sensitivity. It is particularly relevant for research focused on obesity and type 2 diabetes.
Out of stock
All 3 sizes
Synonyms: ZP8396
Petrelintide is a dual amylin and calcitonin receptor agonist (DACRA) that effectively modulates energy intake by selectively reducing high-fat diet consumption in diet-induced obese (DIO) rats. This compound promotes fat mass loss while preserving lean body mass throughout weight reduction processes. Petrelintide is valuable for research in diabetes and obesity, providing insights into the regulation of metabolic pathways associated with these conditions.
Calcitonin (8-32), salmon is a selective antagonist of the amylin receptor, primarily involved in the regulation of glucose homeostasis and appetite control. This peptide exhibits potent inhibitory effects on amylin signaling, making it a valuable tool for research into metabolic disorders and potential therapeutic approaches for conditions such as diabetes and obesity. Its specificity and functionality allow for detailed studies of amylin-related pathways in various biological contexts.
AC 187 is a potent and orally bioavailable antagonist of the amylin receptor, exhibiting an IC50 of 0.48 nM and a Ki of 0.275 nM. This compound demonstrates selectivity for the amylin receptor over calcitonin and CGRP receptors. AC 187 has been shown to possess neuroprotective effects, making it a valuable tool for research in neurodegenerative diseases and metabolic disorders.
CTR/AMYR modulator-1 is a calcitonin receptor/amylin receptor modulator. It exhibits potential in regulating metabolic pathways and can be employed in the study of metabolic diseases. This compound provides a valuable tool for researchers investigating the molecular mechanisms underlying metabolic disorders and the role of these receptors in energy homeostasis.
Out of stock
All 3 sizes
Davalintide is a potent agonist of the amylin receptor, calcitonin receptor, and calcitonin gene-related peptide (CGRP) receptor, demonstrating high affinity with IC50 values of 0.04 nM, 0.06 nM, and 3.1 nM, respectively. It effectively stimulates cyclic AMP production via the calcitonin receptor, with an EC50 of 1.4 nM. Davalintide has been shown to regulate blood glucose levels and body weight through mechanisms such as delaying gastric emptying, inhibiting glucagon secretion, and suppressing food intake. This peptide is valuable for research applications focused on obesity and diabetes management.
Lenbelintide is a dual amylin and calcitonin receptor agonist, designed to engage both receptor pathways. This compound has demonstrated significant biological activity in modulating metabolic processes, making it valuable for research focused on obesity and related metabolic disorders. Its unique mechanism offers insights into appetite regulation and energy expenditure, providing a promising avenue for therapeutic exploration in weight management research.
Acetyl-Amylin (8-37) (human) is a selective antagonist of the amylin receptor. This peptide fragment inhibits amylin activity, providing valuable insights into its role in metabolic processes and glucose homeostasis. It is utilized in research addressing diabetes, obesity, and related cardiovascular conditions, contributing to the understanding of amylin signaling pathways and potential therapeutic interventions.
Out of stock
All 3 sizes
(R)-CTR/AMYR activator-1 is a potent CTR/AMYR activator with EC50 values of 0.8 nM and 0.73 nM. This compound plays a significant role in the regulation of blood glucose levels and bone metabolism. It is useful in researching metabolic disorders and bone health, providing insights into potential therapeutic targets for related diseases.
Out of stock
All 3 sizes